Literature DB >> 19619935

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

Panayiotis A Theodoropoulos1, Hara Polioudaki, Sofia Agelaki, Galatea Kallergi, Zacharenia Saridaki, Dimitris Mavroudis, Vassilis Georgoulias.   

Abstract

The CD44(+)/CD24(-/low) and ALDH1(+) cell phenotypes are associated with stemness and enhanced tumorigenic potential in breast cancer. We assessed the expression of CD44, CD24 and ALDH1 on tumor cells circulating in the peripheral blood (CTCs) of patients with metastatic breast cancer using triple-marker immunofluorescence microscopy. Among a total of 1439 CTCs identified in 20 (66.7%) out of 30 patients, 35.2% had the stem-like/tumorigenic phenotype CD44(+)/CD24(-/low), whereas 17.7% of the CTCs analyzed in seven patients, were ALDH1(high)/CD24(-/low). In conclusion, we report the existence of a subpopulation of CTCs with putative stem cell progenitor phenotypes in patients with metastatic breast cancer. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619935     DOI: 10.1016/j.canlet.2009.06.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  108 in total

Review 1.  Targeting breast cancer stem cells.

Authors:  Suling Liu; Max S Wicha
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

Review 2.  Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?

Authors:  Ana Sofia Azevedo; Gautier Follain; Shankar Patthabhiraman; Sébastien Harlepp; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2015-08-27       Impact factor: 3.405

Review 3.  New promising drug targets in cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2010-03-23       Impact factor: 7.851

4.  Generation of cancerous neural stem cells forming glial tumor by oncogenic stimulation.

Authors:  Ji-Seon Lee; Hong Jun Lee; Bo-Hyun Moon; Seung-Hyun Song; Mi-Ok Lee; Sung Han Shim; Hyung Seok Kim; Min Cheol Lee; Jeong Taik Kwon; Albert J Fornace; Seung U Kim; Hyuk Jin Cha
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

5.  CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.

Authors:  Venktesh S Shirure; Tiantian Liu; Luis F Delgadillo; Chaz M Cuckler; David F J Tees; Fabian Benencia; Douglas J Goetz; Monica M Burdick
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-22       Impact factor: 4.249

6.  Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.

Authors:  Shin-Ae Kang; Nafis Hasan; Aman P Mann; Wei Zheng; Lichao Zhao; Lynsie Morris; Weizhu Zhu; Yan D Zhao; K Stephen Suh; William C Dooley; David Volk; David G Gorenstein; Massimo Cristofanilli; Hallgeir Rui; Takemi Tanaka
Journal:  Mol Ther       Date:  2015-03-27       Impact factor: 11.454

Review 7.  Signatures of breast cancer metastasis at a glance.

Authors:  George S Karagiannis; Sumanta Goswami; Joan G Jones; Maja H Oktay; John S Condeelis
Journal:  J Cell Sci       Date:  2016-04-15       Impact factor: 5.285

Review 8.  Cancer stem cells and their role in metastasis.

Authors:  Yusuke Shiozawa; Biao Nie; Kenneth J Pienta; Todd M Morgan; Russell S Taichman
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

9.  An automated high-throughput counting method for screening circulating tumor cells in peripheral blood.

Authors:  Mengxia Zhao; Perry G Schiro; Jason S Kuo; Karen M Koehler; Daniel E Sabath; Viorica Popov; Qinghua Feng; Daniel T Chiu
Journal:  Anal Chem       Date:  2013-02-06       Impact factor: 6.986

Review 10.  Circulating tumor cells: from bench to bedside.

Authors:  Marija Balic; Anthony Williams; Henry Lin; Ram Datar; Richard J Cote
Journal:  Annu Rev Med       Date:  2012-10-18       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.